Loading...
Loading...
Application UK00915658271 · Registered
| Application Number | UK00915658271 |
| Status | Registered |
| Owner | Rodes Inc. |
| Filed | 2016-07-13 |
| Registered | 2016-11-11 |
| Renewal Due | 2026-07-13 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. SEDOR PHARMACEUTICALS is currently a registered UK trademark, with renewal due on 2026-07-13. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
'SEDOR PHARMACEUTICALS' is a registered trademark on the UK IPO register, owned by Rodes Inc.. The application (UK00915658271) was filed on 13 July 2016 and registered on 11 November 2016. The registration is set to expire on 13 July 2026.
This mark is recorded under multiple classes: Class 35 (advertising, business management & retail services); Class 44 (medical, veterinary & beauty services).
The trademark is represented by Reed Smith LLP.
UK trademark UK00915658271 for the mark 'SEDOR PHARMACEUTICALS' in Class 35, 44 is recorded on the UK IPO register as owned by Rodes Inc.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00915658271 for the mark 'SEDOR PHARMACEUTICALS' as registered.
UK trademark UK00915658271 for the mark 'SEDOR PHARMACEUTICALS' is recorded in Class 35 (advertising, business management & retail services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 35: Business consulting and turnaround services. | Class 44: Advisory services relating to pharmaceuticals; healthcare services.
UK trademark UK00915658271 for the mark 'SEDOR PHARMACEUTICALS' was filed at the UK IPO on 13 July 2016 and registered on 11 November 2016.
UK trademark UK00915658271 for the mark 'SEDOR PHARMACEUTICALS' is currently recorded as valid until 13 July 2026, at which point it will need to be renewed with the UK IPO to remain in force.
Reed Smith LLP is listed as the attorney / representative of record for UK trademark UK00915658271 for the mark 'SEDOR PHARMACEUTICALS' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "SEDOR PHARMACEUTICALS" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| SEDOR PHARMACEUTICALSSame applicant | 86887837 | 602 | 2016-01-27 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.